Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Active not recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 151Lung Neoplasms 34Carcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Neoplasms 9Neoplasm Metastasis 9Mesothelioma 5Adenocarcinoma of Lung 5Uterine Cervical Neoplasms 4Thoracic Neoplasms 4Respiratory Tract Neoplasms 4Respiratory Tract Diseases 4Mesothelioma, Malignant 4Lung Diseases 4Carcinoma, Bronchogenic 4Non-squamous Non-small Cell Lung Cancer 3Non-Squamous Non-Small Cell Lung Cancer 3Neoplasms by Site 3NSCLC 3Bronchial Neoplasms 3Adenocarcinoma 3Recurrence 2Non-Squamous Non-small Cell Lung Cancer 2Non Small Cell Lung Carcinoma NSCLC 2Head and Neck Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1

Interventions

Pemetrexed 2Carboplatin 2Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Non-Squamous Non-small Cell Lung Cancer × Pemetrexed × Clear all
NCT06396065 2026-03-24

Phase III Study of AK112 for NSCLC Patients

Summit Therapeutics

Phase 3 Active not recruiting
420 enrolled
Thoracic

Non-Squamous Non-small Cell Lung Cancer

NCT05184712 2026-03-04

Phase 3 Clinical Study of AK112 for NSCLC Patients

Akeso

Phase 3 Active not recruiting
322 enrolled
Thoracic

Non-Squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡